is there still a glp-1 shortage = Over FDA says shortage of GLP-1

GLP-1 receptor agonists are lab-developed compounds that mimic GLP-1 action at receptors

Blood glucose levels at presentation may be below those typically expected for diabetic ketoacidosis (e.g., less than 250 mg/dL)

Diagnosed with type 2 diabetes in her thirties and then obesity in her fifties, Torres' life was transformed when she was prescribed Ozempic in January 2023

Given the research-backed benefits, even beyond weight loss and blood sugar regulation, Satish Garg, MD, has a bold prediction: I have no doubt in my mind: Going forward, this class of drugs is going to be used by the vast majority of people with type 1 diabetes. Heres what you need to know about the benefits of this treatment and the notable risks

Even for those who do receive a diagnosis, relief isnt necessarily waiting on the other side

Confirm it exists